Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MediWound (MDWD) Total Current Liabilities: 2013-2025

Historic Total Current Liabilities for MediWound (MDWD) over the last 9 years, with Sep 2025 value amounting to $26.3 million.

  • MediWound's Total Current Liabilities rose 2.65% to $26.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.3 million, marking a year-over-year increase of 2.65%. This contributed to the annual value of $26.5 million for FY2024, which is 46.43% up from last year.
  • According to the latest figures from Q3 2025, MediWound's Total Current Liabilities is $26.3 million, which was down 9.69% from $29.1 million recorded in Q2 2025.
  • MediWound's 5-year Total Current Liabilities high stood at $29.1 million for Q2 2025, and its period low was $9.0 million during Q3 2022.
  • For the 3-year period, MediWound's Total Current Liabilities averaged around $22.9 million, with its median value being $22.6 million (2024).
  • Its Total Current Liabilities has fluctuated over the past 5 years, first fell by 14.35% in 2021, then soared by 112.78% in 2023.
  • Quarterly analysis of 5 years shows MediWound's Total Current Liabilities stood at $10.7 million in 2021, then rose by 12.46% to $12.1 million in 2022, then skyrocketed by 50.33% to $18.1 million in 2023, then surged by 46.43% to $26.5 million in 2024, then climbed by 2.65% to $26.3 million in 2025.
  • Its last three reported values are $26.3 million in Q3 2025, $29.1 million for Q2 2025, and $21.8 million during Q1 2025.